Food and Drug Administration approved Wegovy (the first GLP-1 medicine aimed at weight loss) in mid-2021, sales of the drug and related GLP-1 meds such as Ozempic, Mounjaro and Zepbound have soared
berberine acts through multiple, less specific pathways
If the full 2.4 mg dose suppresses your appetite so aggressively that you can't hit protein or carb targets, discuss staying at a lower maintenance dose with your provider
This allows for immediate benefits such as improved skin radiance, enhanced liver detoxification, and increased energy levels
The immune system mistakenly attacks the protective myelin sheath surrounding nerve fibres in the brain and spinal cord, causing inflammation and damage
This takes about two minutes and determines whether you are a potential candidate for GLP-1 medication